| Wednesday April 14, 2010 |
| 6:00 – 8:00 P.M. |
Registration |
| |
| Thursday April 15, 2010 |
| 6:30 - 7:15 |
Registration and Continental Breakfast |
| 7:15 - 7:30 |
Introduction, Symposium Goals and Welcome from the
Heart Valve Society of America
Jeffrey S. Borer, M.D. |
| 7:30 – 7:35 |
Welcome from the American College of Cardiology
Andrew Van Tosh, M.D.
President, American College of Cardiology, New York State Chapter |
| 7:35 - 7:40 |
Welcome from the Society for Heart Valve Disease
Friedrich Mohr, M.D., Ph.D.
|
OVERVIEW
Chairman: O. Wayne Isom, M.D.
(7:40 - 9:30) |
| 7:40 - 7:55 |
The epidemiology of valvular heart diseases: Does the growth curve continue? |
| 7:55 - 8:10 |
Systolic and diastolic dysfunction in valve diseases: What do you need to know to select therapy? |
| 8:10 - 8:25 |
Patient preparation to optimize anesthesia for valve surgery — what must we do and when do we do it? |
| 8:25 - 8:40 |
Drug therapy for regurgitant valve diseases — why doesn’t it work? |
| 8:40 - 8:55 |
Use of VAD, surgical & interventional in valvular heart disease |
| 8:55 - 9:10 |
Regulation of valve development: Current concepts and requirements |
| 9:10 - 9:30 |
Panel Discussion/Q & A
|
| 9:30 - 10:40 |
Coffee Break
ORAL PRESENTATIONS OF REFEREED ABSTRACTS
Aortic valve natural hx and prediction
Aortic valve surgery I
Aortic valve imaging
Aortic valve biology
Aortic valve protheses
Aortic valve and aortic aneurysm surgery II
Prosthetic valves
|
| 10:40 – 11:00 |
THE HOWARD GILMAN FOUNDATION LECTURE
Transapical valve replacement/repair
Friedrich Mohr, M.D. |
|
AORTIC VALVE DISEASE I
Chairman: Warren Laskey,, M.D.
(11:00 - 12:20) |
| 11:00 – 11:15 |
When should we operate for asymptomatic AS? |
| 11:15 – 11:30 |
Who is too sick for AVR? Low flow/low gradient A, low ER AR |
| 11:30 – 11:45 |
Statins to prevent AS progression: Has the hypothesis been disproven? The SEAS trial and its implications |
| 11:45 – 12:00 |
Tissue factor inhibition to prevent valve calcification: Is this the response to statin failures? |
| 12:00 – 12:20 |
Panel Discussion/Q & A
|
| 12:30 – 2:00 |
Lunch/Symposia |
| 12:35 – 2:00 |
SYMPOSIA
Surgical Answers to the Small Aortic Root
Supported by St. Jude Medical
Percutaneous Aortic Valve
Severe aortic stenosis with heavy calcification: Should we be more aggressive even if surgery is possible?
Paravalvular leaks – current incidence and planned remedies
Regulation of Valve Development
New FDA draft guidelines on heart valves
ISO standards for valve manufacturing
Considerations in clinical trial design for percutaneous heart valves
Re-operation – Options and Techniques – Percutanous vs Open chest
Cerebral protection during valve surgery: does it work? Impact on reoperation
Re-operation after aortic root repair with valve replacement: Current techniques and results
Transapical and transfemoral redo “valve in valve” operations: Is this concept changing practice patterns? |
| 2:00 - 3:00 |
CASE PRESENTATIONS
ORAL PRESENTATIONS OF REFEREED ABSTRACTS:
Tissue engineering
Anti-cogulation and bleeding
Epidemiology
Imaging
Surgical methodology |
AORTIC VALVE DISEASE II
Chairman: Robert Emery, MD
(3:00 - 5:30) |
| 3:00 – 3:15 |
Patient prosthetic mismatch: What do you do? |
| 3:15 – 3:30 |
Indication for operation AR: The symptomatic and asymptomatic patient |
| 3:30 – 3:45 |
Bicuspid aortic valve: Management with exercise restriction, medication, or root replacement?. |
| 3:45 – 4:00 |
Aortic valve repair — will it ever be a sustainable solution? |
| 4:00 – 4:15 |
Who is too sick for AVR? Low flow/low gradient AS, low EF AR |
| 4:15 – 4:30 |
Apical-aortic conduit for aortic stenosis: When, why and current outcomes |
| 4:30 - 5:15 |
Panel Discussion/Q & A
|
| |
| Friday April 16, 2010 |
| 6:00 - 6:45 |
Continental breakfast |
| 6:45 – 8:15 AM |
SYMPOSIUM AND ORAL PRESENTATIONS OF REFEREED ABSTRACTS
SYMPOSIUM
Imaging: Echo (2D, 3D), CT, MRI
When should Cox maze or its variants be added to mitral valve operations?
Mitral Annular Geometry: Insights from 3D and Clinical Implications
Ischemic Mitral Regurgitation: 3D Insights
Panel/Q&A
ORAL PRESENTATIONS OF REFEREED ABSTRACTS
Mitral valve surgery
New protheses and other devices
Cathether-based valve therapy
Drugs and metabolism
Surgical potpourri
Surgical and catheter-based approaches
|
MITRAL REGURGITATION I
Chairman: Cary Akins, MD
(8:15 - 10:30) |
| 8:15 – 8:30 |
Echocardiographic quantitation of MR |
| 8:30 – 8:45 |
Indications for mitral valve surgery for degenerative mitral regurgitation: impact of regurgitation severity vs symptoms, ventricular function, atrial rhythm. |
| 8:45 – 9:00 |
Mitral valve surgery for degenerative disease: Resection of diseased leaflet tissue versus chordal replacement. |
| 9:00 – 9:15 |
Should pre-operative imaging define the surgeon’s approach or is intraoperative imaging/observation sufficient? |
| 9:15 – 9:30 |
Indications for mitral valve surgery for secondary MR: Ischemic and cardiomyopathic |
| 9:30 – 9:45 |
Mitral regurgitation in cardiomyopathy should be managed medically
Debate: Pro & Con
|
| 10:00 – 10:30 |
Panel Discussion/Q & A |
MITRAL VALVE DISEASE II
Chairman: Maurice E. Sarano, MD.
(10:30 - 12:00) |
| 10:30 -10:45 |
Mitral reconstruction with mitral annular calcification |
| 10:45 - 11:00 |
Mitral valve atherosclerosis and calcification: Is there a medical approach? |
| 11:00 - 11:15 |
Coronary Disease and MR: When do you fix both? |
| 11:15 – 11:30 |
Differential efficacy of current mitral annuloplasty rings |
| 11:30 – 12:00 |
Panel Discussion/Q&A |
| 12:30 – 2:00 |
LUNCH/SYMPOSIA
Mitral valve surgery – new techniques
Supported by St. Jude Medical
Mitral valve leaflet re-suspension for HOCM
Simplification of mitral valve repair techniques
Selection of repair technique for ischemic MR
Cutting chordae tendineae to the central portion of mitral leaflets in ischemic MR: impact on function and outcome
Sutureless Aortic Prostheses
Supported by Sorin Group
New insights into biological mechanisms of AS
New approaches to management of AS in the asymptomatic patient
New perspective for surgical management of AVR for aortic stenosis: Sutureless valve technology
Allied Health Professionals in VHD Care
Home monitoring of INR: How are we doing?
Patient education: Materials and methods
Practical problems of anticoagulation products
|
MITRAL VALVE III
Chairman: David Adams, M.D.
(2:15 - 4:00) |
| 2:15 - 2:45 |
Debate:
In patients with VHD, surgery is superior to catheter-based pulmonary vein isolation for AF
Debate: Pro & Con |
| 2:45 – 3:00 |
Robotic surgery: when is it NOT appropriate? |
| 3:00 – 3:15 |
Percutaneous mitral valve repair: Where do we stand? |
| 3:15 – 3:30 |
Mitral Stenosis: Catheter vs surgery — current indications and results |
| 3:30 - 4:00 |
Panel Discussion/Q & A
|
| 4:00 – 5:40 |
CASE PRESENTATIONS
Case Presentations I
Case Presentations II
|
| 6:00 - 6:30 HVSA BUSINESS MEETING |
| 6:30 - 10:00 FACULTY DINNER |
| |
| Saturday April 17, 2010 |
| 6:00 – 6:45 |
Continental breakfast |
| |
|
| 6:45 – 8:15 |
SYMPOSIUM AND ORAL PRESENTATIONS OF REFEREED ABSTRACTS
SYMPOSIUM
Bioprostheses – new developments
The Ross Procedure: Does it still have a place?
Porcine bioprostheses in the mitral position: Are they viable?
Artificial materials: Most recent developments
Current status of tissue engineering
Current role of the stentless aortic valve prosthesis
ORAL PRESENTATIONS OF REFEREED ABSTRACTS
Mitral valve surgery
New prostheses and other devices
Imaging and hemodynamics
Infection/endocarditis and Epidemiology/prognostication |
MISCELLANEOUS
Chairman: Jagat Narula, M.D.
(8:15 - 9:30) |
| 8:15 - 8:30 |
Prevention of infective endocarditis: Guidelines or an individualized approach? |
| 8:30 - 8:45 |
When and how to correct tricuspid regurgitation. |
| 8:45 - 9:00 |
Double valve disease: are there any objective bases for operation? |
| 9:00 - 9:15 |
Use of VAD, surgical and interventional, in VHD |
| 9:15 - 9:30 |
Indications and results of reoperation for paravalvular leaks |
| 9:30 - 10:00 |
Panel Discussion/Q&A |
| 9:45 -- 11:45 |
CASE PRESENTATIONS AND DISCUSSION
|
| 11:45 – 11:55 |
Closing Remarks |
| 11:55– 12:00 |
Participants complete and submit course evaluation and CME form |
